MORA Cure for Knee Osteoarthritis With Anterior Knee Pain
Key facts
- Who runs it
- EverEx Inc.
- Where
- South Korea2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 44 people, planned
- Started
- 10 Jul 2026
- Expected to end
- 28 Feb 2027
- Type of study
- Interventional
- Treatments tested
- MORA Cure
- Record updated
- 18 August 2026
Who can take part
- Age
- 51 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adults older than 50 years
- Kellgren-Lawrence grade 1 or higher on weight-bearing plain radiographs of the study knee
- Osteoarthritis-related pain in the study knee for at least 3 months
- Anterior knee pain in the study knee involving the peripatellar, anterior patellar, or retropatellar region, with clear provocation or worsening of anterior knee pain during at least one patellofemoral joint-loading activity: stair ascent or descent, squatting, or rising from a chair
- If medial, lateral, or posterior knee pain is also present, the participant is able to distinguish and separately report anterior knee pain
- Voluntary written informed consent before study participation
Who cannot take part
- Acute injury of the study knee within the previous 3 months, including fracture, ligament tear, or meniscal tear requiring surgical treatment or immobilization
- Injection therapy to the study knee within the previous 3 months
- Acute attack of gout or pseudogout in the study knee within the previous 3 months
- Previous total knee arthroplasty, corrective osteotomy, or other major surgery affecting knee alignment or joint structure in the study knee
- Any other condition that, in the investigator's judgment, makes the participant unsuitable for the study
- Current use of opioid analgesics for pain control
- Does not own a smartphone or is unable to use the mobile application
- Current participation in another clinical trial or planned participation in another clinical trial during this study
- Diagnosed active inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, or reactive arthritis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective, multicenter, single-arm, sponsor-initiated pilot study will evaluate the clinical course and safety of MORA Cure in adults older than 50 years with knee osteoarthritis accompanied by anterior knee pain. Participants will use MORA Cure for 8 weeks. MORA Cure provides personalized rehabilitation exercises and cognitive behavioral therapy-based content through a patient mobile application supported by a clinician web portal. Clinical outcomes will be assessed at baseline, Week 4, and Week 8. The planned enrollment is 44 participants at two sites in the Republic of Korea.
The group in the trial
- Experimental: MORA CureTreatment being tested
Participants will use MORA Cure for 8 weeks. Personalized rehabilitation exercises are performed at least 3 times per week for approximately 30 minutes per session, and cognitive behavioral therapy content is completed according to weekly sessions.
Treatment: MORA Cure
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Multicenter, Single-Arm, Pilot Study to Evaluate the Clinical Outcomes and Safety of the Digital Therapeutic MORA Cure in Patients With Knee Osteoarthritis Accompanied by Anterior Knee Pain: 8-week
- Record updated
- 18 August 2026